Join or Renew With AARP for Just $16 a Year
- Discounts on travel and everyday savings
- Subscription to AARP The Magazine
- A voice in Washington and in your community
- Free membership for your spouse or partner
What the heck is going on with doctors in some parts of the country who prescribe risky drugs for older adults? According to an analysis of more than 6 million seniors on Medicare Advantage, more than 20 percent are prescribed at least one high-risk medication. The problem is most common in the South, among women, and in relatively poor areas, report public health researchers with Brown University. Risky medications are ones that health authorities have specifically recommended against prescribing to …
A study published yesterday in the Archives of Internal Medicine shows many prescription drugs could have a longer shelf life than assumed, in some cases much longer. But while the results could have important implications for drug companies, researchers are quick to caution consumers against applying the findings to their own medicine cabinets.
Talk about frightening: Only 3 percent of online pharmacies meet state and federal laws, yet a new government survey finds that one in four Internet customers has purchased prescription medications from a pharmacy they found online. At the same time, said the Food and Drug Administration (FDA), nearly 30 percent surveyed said they lack confidence in making safe online medication purchases. As proof of the problem, the FDA announced this week that they have cracked down on thousands of online …
One in four Americans over age 45 take the cholesterol-lowering drugs collectively known as statins. Recently, some researchers have raised concern that these drugs could increase diabetes risk, especially among post-menopausal women or people taking high statin doses. But a large new analysis shows that the cardiovascular benefits of statins outweigh diabetes concerns, even for high-risk groups.
An experimental treatment for Alzheimer’s disease has turned out to be a disappointment in the first finished late-stage study, manufacturer Pfizer said Monday. Called bapineuzumab, it’s one of three Alzheimer’s treatments currently in clinical trials that some have been calling our “last hope” for drugs that slow the progression of the disease.
You know those colorful little warning stickers that the pharmacist slaps on prescription pill bottles? Actually, you might not. A new study says that most older adults ignore them, while most younger people read them. Michigan State University researchers used eye-tracking technology as well as follow-up memory tests to see whether people paid attention to the pill container stickers that say things like, “Do not consume alcohol while taking this medication,” or “Take with food.” They found that while everyone …